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Tumorigenesis and Neoplastic Progression
Snai2 Expression Enhances Ultraviolet
Radiation-Induced Skin Carcinogenesis
Kimberly M. Newkirk,* Allison E. Parent,*
Stacey L. Fossey,* Changsun Choi,*
Heather L. Chandler,* Pa¨ivi J. Rajala-Schultz,†
and Donna F. Kusewitt*
From the Departments of Veterinary Biosciences* and Veterinary
Preventive Medicine,† College of Veterinary Medicine, The Ohio
State University, Columbus, Ohio
Snai2, encoded by the SNAI2 gene, has been shown to
modulate epithelial-mesenchymal transformation (EMT),
the conversion of sessile epithelial cells attached to ad-
jacent cells and to the basement membrane into disso-
ciated and motile fibroblastic cells. EMT occurs during
development, wound healing, and carcinoma progres-
sion. Using Snai2-nullmice (Snai2lacZ), we evaluated the
role of Snai2 in UV radiation (UVR)-induced skin carci-
nogenesis. In chronically UVR-exposed nontumor-bear-
ing skin from Snai2-null mice, inflammation and epi-
dermal proliferation were decreased compared with
wild-type (/) skin. Snai2-nullmice had a consistently
lower tumor burden than / mice. In addition, null
mice developed fewer aggressive spindle cell tumors,
believed to arise from squamous cell carcinomas that
have undergone EMT, than / mice; however, the
difference in tumor type distribution between the two
genotypes was not statistically significant. No metasta-
ses were observed in either the/ or Snai2-null mice.
Using quantitative reverse transcriptase-polymerase
chain reaction and immunohistochemistry, we showed
that the spindle cell tumors in the Snai2-null mice dem-
onstrated impaired EMT, as shown by decreased vimen-
tin and increased cadherin 1 expression. This study con-
firms a role for Snai2 in EMT, but demonstrates that
Snai2 expression is not required for the development
or progressionofUVR-induced skin tumors. (Am J Pathol
2007, 171:1629–1639; DOI: 10.2353/ajpath.2007.070221)
The process of epithelial-mesenchymal transformation
(EMT) occurs at several stages of embryonic develop-
ment, including gastrulation and neural crest cell migra-
tion.1 EMT is characterized by loss of cell/cell adhesion
mediated by desmosomes and adherens junctions, in-
creased secretion of extracellular matrix-degrading pro-
teases, enhanced motility, loss of cytokeratin expression,
and de novo expression of vimentin.2 Neoplastic cells may
recapitulate these normal developmental processes, ex-
ploiting them to foster tumor growth and spread. Certain
poorly differentiated carcinomas have been found to lose
desmosomes and adherens junctions, express vimentin,
acquire a spindle cell phenotype, overexpress proteases,
and become highly motile; these changes are associated
with enhanced invasive and metastatic potential.1,3–6 Dys-
regulation of genes important in developmental EMT has
been implicated in these EMT-like processes.7
Two highly conserved members of the Snail family of
zinc-finger transcription factors, Snai1 (Snail) and Snai2
(Slug), play roles in developmental EMT.1 Snai1 and
Snai2 recognize and bind to the same DNA sequence;
however, their transcriptional regulatory activities are not
identical,8,9 and they play distinct roles during develop-
ment, as shown by spatial and temporal differences in
their patterns of expression.10 In addition, although Snai1
expression is essential for normal embryonic develop-
ment in mice, Snai2-null embryos are viable.11 Snai2-null
mice are small, with minor craniofacial defects, pigmen-
tary alterations, macrocytic anemia, and increased apo-
ptosis in the thymic cortex.11–13 Snai2 also seems to in-
duce EMT-like events in adult epithelial cells. Constitutive
expression of murine Snai2 in a rat bladder epithelial cell
line in vitro causes dissociation of desmosomes, increased
cell spreading, and cell dispersion.14 Our previous studies
indicated that SNAI2 expression is induced in keratinocytes
undergoing EMT: SNAI2 is expressed at the margins of
healing wounds in vitro and in vivo, and expression of exog-
enous Snai2 in keratinocytes enhances their ability to re-
epithelialize wounds in vitro.15 Expression of exogenous
SNAI2 in keratinocytes is associated with enhanced migra-
tion, decreased desmosome number, redistribution of des-
mosomal proteins from the cell membrane to the cytoplasm,
and decreased integrin expression.15,16
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The final stage of malignant progression in mouse
epidermal carcinogenesis involves the evolution from
squamous cell carcinoma (SCC) to the highly aggressive
spindle cell tumor.17 This transition from epithelial to spin-
dle cell morphology resembles EMT and has been asso-
ciated with epigenetic alterations that include cadherin 1
(Cdh1; E-cadherin) methylation, demethylation of the
SNAI1 promoter, and a global decrease in DNA methyl-
ation.18 We have shown that UVR exposure induces
Snai1 and Snai2 expression in the epidermis of mice.19
Persistent elevation of the encoded mediators in re-
sponse to chronic UVR exposure may promote the pro-
gression of UVR-induced SCC through their ability to
modulate cell adhesion, motility, proliferation, and apo-
ptosis.19 To test this prediction, we examined the contri-
bution of Snai2 to the development of UVR-induced non-
melanoma skin tumors in a mouse model. This study was
the first to test directly the role of Snai2 in the de novo
development of tumors in response to a complete car-
cinogen. Snai2-null mice developed skin tumors when
chronically exposed to UVR, demonstrating that Snai2
expression is not required for skin carcinogenesis. How-
ever, the Snai2-null mice had a lower tumor burden and
developed fewer aggressive spindle cell tumors than
/ mice. In addition, the spindle cell tumors in Snai2-
null mice had a more epithelial gene expression profile
than those in / mice.
Materials and Methods
Mice
Inbred 129S1/SvImJ mice used for this study (originally the
kind gift of Dr. Thomas Gridley, Jackson Laboratory, Bar
Harbor, ME) have been described previously.11 In these
mice, the -galactosidase gene has been inserted into the
Snai2 gene, resulting in the production of a mutant allele
(Snai2lacZ) that encodes a fusion protein lacking Snai2 ac-
tivity. Twenty wild-type (/) and 20 Snai2-null mice were
included in the study. Thirteen of the mice in each group
were females and seven were males. Mice were obtained
from a breeding colony maintained at the Ohio State Uni-
versity. The breeding colony was maintained in ventilated
microisolator cages; cages were opened and mice were
manipulated in a class II biosafety cabinet. Sentinel mice on
each rack were housed in contact with soiled bedding and
tested quarterly by serology, tape testing, gut maceration,
bacterial culture, and PCR for common rodent pathogens,
including viruses, parasites, and bacteria. All sentinel mice
from the breeding colony remained free of pathogens, ex-
cept for murine norovirus.
UVR Exposure
UVR was provided by Kodacel-filtered Westinghouse
FS-40 lamps that emitted wavelengths between 280 and
400 nm, with a peak at 313. Based on determinations of
skin thickness, 1600 J/m2 represented 1 minimal erythe-
mal dose. Beginning at 10 to 12 weeks of age, the mice
were exposed to 3200 J/m2 (2 minimal erythemal doses)
of UVR three times a week for 50 weeks. Forty-eight hours
before the first UVR dose, the mice were shaved and
excess hair was removed using Nair. Immediately before
the first UVR exposure, skin thickness was determined by
measuring the thickness of a skin tent with digital calipers in
three different areas of the back; these individual values
were then averaged. Skin thickness was measured before
every UVR exposure for the first 2 weeks and then once
weekly until week 42, when most mice had developed tu-
mors. Once tumors were noted, tumor size and location
were monitored weekly. Mice with tumors exceeding 1 cm
were removed early from the study. All remainingmice were
sacrificed at week 50 by carbon dioxide asphyxiation.
Histopathology
Immediately after death, samples of nontumor skin, the
entirety of each tumor less than 3 mm in diameter, and half
of each tumor larger than 3 mm in diameter were fixed in
10% neutral buffered formalin. The right inguinal lymph
node, cervical lymph nodes, thymus, spleen, mesenteric
lymph nodes, liver, kidneys, heart, and lung of each mouse
were also fixed for histological examination. Formalin-fixed
samples were embedded in paraffin, sectioned at 4- to 5-m
thickness, and stained with hematoxylin and eosin (H&E).
Tumors identified grossly were classified based on their
histological appearance as hyperplasia, papillomas, micro-
invasive squamous cell carcinomas (miSCCs), SCCs, spin-
dle cell tumors, or anaplastic tumors (Figure 1, A–L). Hyper-
plastic lesions were focal areas of increased epidermal
thickness, without significant dysplasia, exophytic growth,
or hyperkeratosis. Because these hyperplastic lesions were
not true neoplasms, they were excluded from further con-
sideration. A papilloma was defined as a focal area of
increased epidermal thickness with an exophytic growth
pattern, hyperkeratosis, and minimal dysplastic change.
MiSCCs were similar to papillomas, except there was evi-
dence of penetration of the basement membrane with inva-
sion of basal cells into the surrounding stroma; these tumors
remained confined to the dermis. SCC demonstrated exten-
sive invasion into the dermis and often invaded the pannic-
ulus carnosus. Neoplastic epithelial cells in SCC were fre-
quently dysplastic, and keratin pearls were present. Spindle
cell tumors varied in their extent of invasion but demon-
strated loss of the epithelial phenotype; most neoplastic
cells had a spindleoid morphology, and cornification was
not observed. Anaplastic tumors also varied in their extent
of invasion; cells were markedly atypical with frequent
karyomegaly and numerous mitotic figures.
Immunohistochemistry and Histochemistry
Formalin-fixed paraffin-embedded tissue specimens were
sectioned at 4 m and mounted on glass slides. The spec-
imens were deparaffinized, rehydrated, pretreated with
DAKO target retrieval solution (DAKO, Carpinteria, CA) us-
ing a digital decloaking chamber (Biocare Medical, Con-
cord, CA) and then heated to 125°C for 30 seconds for
antigen retrieval. Peroxidase blocking was performed with a
3% peroxidase solution for 5 minutes. Serum-free protein
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block (DAKO) was applied for 10 minutes. Primary antibod-
ies included polyclonal rabbit anti-Cd3e (Cd3e; DAKO) di-
luted 1:100, monoclonal rat anti-mouse keratin 8 (Krt8; De-
velopmental Studies Hybridoma Bank, University of Iowa
Department of Biological Sciences, Ames, IA) diluted 1:250,
monoclonal rat anti-mouse anti-Ki-67 (Mki67; DAKO) diluted
1:200, and rabbit anti-mouse keratin 14 (Krt14; Covance
Research Products, Berkeley, CA) diluted 1:10,000. All an-
tibodies were diluted in DAKO antibody diluent and applied
to the slides for 30 minutes. Sections were incubated with
biotinylated secondary antibody (rabbit anti-rat, anti-mouse,
or anti-rat) (Vector Laboratories, Burlingame, CA) diluted
1:200 in serum-free protein block for 30 minutes, followed
by a 30-minute incubation with ABC reagent (R.T.U. Vec-
tastain Elite ABC; Vector Laboratories), a 5-minute incuba-
tion with chromogen (liquid DAB substrate; DAKO), and
hematoxylin counterstaining. Rinses were performed using
DAKO wash buffer (DAKO). The slides were then dehy-
drated and coverslipped.
For Cdh1 detection, slide preparation, antigen retrieval,
and blocking were performed as previously described. The
biotinylated goat anti-mouse E-cadherin (Cdh1; R&D Bio-
systems, Minneapolis, MN) diluted with DAKO antibody
diluent to 15 g/ml and then applied to the slides for 30
minutes. Chromogen development, counterstaining, dehy-
dration, and coverslipping were then performed as previ-
ously described. Routine acid fast staining was used to
identify dermal mast cells.20
Figure 1. Tumors and tumor-like lesions were classified histologically as hyperplasia (A and D), papilloma (B and E), microinvasive SCC (C and F), SCC (G and
J), spindle cell tumor (H and K), or anaplastic tumor (I and L). Original magnifications: 40 (A–C, G–I); 200 (D–F, J–L).
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Morphometry
Epidermal thickness was determined using an ocular
micrometer. Six different fields per mouse were mea-
sured at a magnification of 600 and the values from
each mouse were averaged. The number of dermal neu-
trophils and mast cells in the nontumor chronically ex-
posed skin was counted on H&E-and acid-fast-stained
sections, respectively. Neutrophils and mast cells were
counted in six different 400 fields per mouse, and the
values were averaged. Cd3e-positive cells with strong
cytoplasmic immunoreactivity were counted in the epi-
dermis and dermis of different 400 fields. These num-
bers were averaged for each genotype and compared
with the Cd3e-positive cell counts from five / and five
null mice not exposed to UVR. In each of these fields, the
total number of epidermal cells was also counted, and
the number of Cd3e-positive epidermal cells was ex-
pressed as a percentage of total epidermal cells. The
epidermal cell count also served as an indicator of epi-
dermal thickness.
For Krt8, Krt14, and Cdh1 immunoreactivity, tumors
were graded on a scale of 0 to 3. Grade 0 tumors had no
immunoreactivity; grade 1 tumors had 1 to 5% immu-
nopositive cells; grade 2 tumors had 5 to 10% immunopo-
sitive cells; grade 3 tumors had 10 to 15% immunoposi-
tive cells. For Mki67 immunoreactivity, spindle cell tumors
were graded on a scale of 1 to 3. Grade 1 tumors had 0
to 25% immunopositive epidermal cell nuclei; grade 2
tumors had 25 to 50% immunopositive nuclei; grade 3
tumors had 50 to 75% immunopositive epidermal nuclei.
Quantitative RT-PCR
Samples of nontumor skin from all mice and half of each
tumor larger than 3 mm were frozen in liquid nitrogen for
subsequent RNA analysis. Frozen tumor samples were ho-
mogenized in TRIzol (Invitrogen, Carlsbad, CA) for RNA
isolation. Five g of pooled total RNA was treated with
DNaseI (Ambion, Austin, TX), and cDNA was produced by
reverse transcription of 500 ng of this RNA using Super-
script II (Invitrogen) and oligo(dT) primers, as directed by
the manufacturer. Quantitative RT-PCR was performed us-
ing primer sets for glyceraldehyde-3-phosphate dehydro-
genase (Gapdh; 5-TGATGACATCAAGAAGGTGAAC-3/
5-ATGGCCTTACATGGCCTCCAAGG-3), Snai2 (5-GAT-
GTGCCCTCAGGTTTGAT-3/5-ACACATTGCCTTGTGTC-
TGC-3), Snai1 (5-CTCACTGCCAGGACTCCTTC-3/5-
TGTCCAGAGGCTACACCTCA-3, Cdh1 (5-GGTCTCTT-
GTCCCTTCCACA-3/5-CCTGACCCACACCAAAGTCT-3,
vimentin (Vim) (5-AATGCTTCTCTGGCACGTCT-3/5-
GCTCCTGGATCTCTTCATCG-3), and matrix metallo-
protease-2 (Mmp2; 5-CACCTACACCAAGAACTTCC-3/
5-GAACACAGCCTTCTCCTCCT-3). The Brilliant SYBR
Green QPCR mix (Stratagene, La Jolla, CA) was used as
directed with 100 nmol/L of each primer in an MX3000P
real-time PCR system (Stratagene). Fifty cycles at 94°C
(30 seconds), 60°C (30 seconds), and 72°C (30 sec-
onds) were performed. The data analyzed in this study
were collected between cycles 15 and 35. The negative
controls were consistently negative even after the full 50
amplification cycles. RNA concentrations were calcu-
lated using the LinReg PCR program, which uses four
points in the best linear region of amplification to deter-
mine starting mRNA concentration and PCR efficiency for
each sample.21 Gapdh was used as an internal standard
to account for efficiency of reverse transcription and am-
plification. Expression values for each primer set were
normalized to Gapdh values. For all quantitative RT-PCR
analyses, three replicate PCRs were performed.
Statistics
Skin thickness, tumor number, and tumor area were de-
termined by weekly observation. For comparison of tumor
grade, tumors that were too small for histopathological
analysis and those classified histologically as hyperpla-
sia were not included. Pooled data for male and female
mice of each genotype were compared as follows: a
one-tailed t-test, assuming equal variance was applied to
the skin thickness data, basic tumor data, tumor burden
data, and quantitative RT-PCR data, and distribution of
tumor classes in the genotypes was compared by Fisher’s
exact test. Time to tumor onset in the genotypes was
compared by the Kaplan-Meier statistic. To test for dif-
ferences between the sexes within each genotype, non-
parametric statistical approaches were used because of
the small sample sizes. Fisher’s exact test was used to
determine whether the occurrence of tumors differed and
the Wilcoxon rank-sum test was used to assess whether
there was a difference in tumor area or number of tumors
per mouse. Significance was defined as a P value less
than or equal to 0.05.
Results
Skin Thickness
Before UVR exposure, skin from the null mice was signif-
icantly thinner than that of the/mice (0.82 mm 0.31
versus 1.03 mm  0.12, P  0.02), as measured by
caliper; therefore, skin thickness was calculated as per-
cent change compared with pre-exposure thickness. To-
tal skin thickness in / mice peaked during the second
week of UVR exposure at 163  38.9% of the initial value
versus 110  38.9% of the initial value in the null mice;
however, this difference was not significant (P  0.07).
By 6 weeks of exposure, skin thickness in the / mice
had reached a minimum (61.5  22.8% of initial thick-
ness). At this time point, the skin thickness of the null
mice had also declined (62.8  76.6% of initial thick-
ness); the difference between the two genotypes was not
significant (P  0.5). The skin thickness of the null mice
subsequently continued to decline, reaching a minimum
by 9 weeks (20.8 34.8% of initial value), meanwhile skin
thickness of the / mice remained at 66.8  17.7% of
the initial value; the difference between the genotypes
was significant (P  0.0007) at this time point. Through-
out the remainder of the study, skin thickness in all mice
progressively increased. The final skin thickness mea-
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surements were taken after 42 weeks of exposure, and, at
that time,/ skin was significantly thicker than null skin;
/ skin was 107  32.2% of the initial thickness,
whereas null skin was 37.9  21.7% of the thickness
before the beginning of the study, (P  4  105).
The epidermis of unexposed Snai2-null mice, mea-
sured in histological sections of skin of control mice, was
significantly thinner than that of / mice (7.38  0.99
m versus 8.91  1.67 m, P  0.02). At the termination
of the present study, the epidermal thickness measured
from histological sections was significantly lower in null
mice compared with the / mice (8.91  1.67 m
versus 7.38  0.99 m, P  0.02). In unexposed null
mice, there were 90.7  8.18 epidermal cells per 400
field compared with 126.5  31.9 epidermal cells in null
mice exposed to UVR for 50 weeks (P  0.01). In unex-
posed / mice, there were 93.6  11.0 epidermal cells
per 400 field compared with 157.4  23.2 epidermal
cells in the chronically exposed / mice (P  3 
106). Thus, there were significantly fewer epidermal
cells per field in Snai2-null mice in unexposed skin and
after chronic UVR exposure. Reduced epidermal thick-
ness in Snai2-null mice both before and after chronic UVR
exposure was consistent with the reported roles for Snai2
in epidermal differentiation and proliferation.19,22
Inflammation
Only occasional neutrophils were observed in the dermis
of colony control Snai2-null and / mice. After chronic
UVR exposure, there was no difference in the number of
dermal neutrophils between the / and Snai2-null mice
(2.23  1.18 cells versus 2.27  1.46 cells per 400
field, P  0.5) (Figure 2A). Significantly more mast cells
were present in the dermis of unexposed control Snai2-
null mice compared with / mice (13.03  4.35 cells
versus 9.17  3.21 cell per 400 field, P  0.05). A
similar significant difference was seen after chronic UVR
exposure (15.56  3.65 cells per 400 field in null mice
versus 12.18  4.31 cells per 400 field in / mice,
P  0.006) (Figure 2B). There was no difference in the
number of Cd3e-positive cells in the dermis of skin from
unexposed control Snai2-null and / mice (Figure 2C).
However, in response to chronic UVR exposure, there was
a significant increase in Cd3e-positive cells in the dermis of
the / mice (35.30  2.81 per 400 field in unexposed
mice versus 54.42 11.77 per400 field in UVR-exposed
mice, P 0.0009); a similar increase in Cd3e-positive cells
did not occur in the dermis of Snai2-null mice (38.33 7.85
per 400 field in unexposed mice versus 44.24  7.70
per 400 field in UVR-exposed mice, P  0.2). As a result,
there were significantly more Cd3e-positive cells in the der-
mis of the / mice than the null mice in response to
chronic UVR exposure (P  0.02).
Tumor Development
The first tumor was noted at week 29 of UVR exposure in
a Snai2-null mouse. As shown in Figure 3 and Table 1,
there was no significant difference in time to tumor onset
between the two genotypes. Sixteen of the 20 / mice
(80%) developed skin tumors. Only 13 of 20 (65%) of null
mice developed tumors; however, seven null mice were
removed early from the study because of problems un-
related to UVR exposure (for example, inanition, pria-
pism, and preputial gland abscess); 13 of 18 (72%) of the
Figure 2. There were differences in inflammatory cell infiltrates in chroni-
cally UVR-exposed nontumor skin from/ and Snai2-null mice. A: In both
genotypes, there were markedly increased numbers of neutrophils in the
chronically exposed skin, compared with the unexposed skin, in which
neutrophils were rarely observed. There was no difference in the number of
neutrophils between / and Snai2-null mice. B: There were significantly
more mast cells in the chronically exposed Snai2-null skin, compared with
/ skin. *P  0.05. C: Increased numbers of Cd3e-positive cells were
present in the dermis after chronic UVR exposure, with significantly fewer
Cd3e-positive cells in the chronically exposed Snai2-null skin, compared
with / skin. *P  0.0009.
Figure 3. There was no difference in the time to tumor onset between the
/ and Snai2-null mice as shown in this Kaplan-Meier plot.
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null mice that remained on the study past week 35 de-
veloped skin tumors.
When tumor burden, calculated as total tumor area per
mouse per week (including hyperplastic lesions), was
compared between genotypes (Figure 4), the / mice
consistently had a higher tumor burden. This difference
between the / and null mice was significant at weeks
39 (1.14  2.60 versus 0  0, P  0.04), 41 (4.08  6.60
versus 1.02  2.78, P  0.04), 42 (7.52  12.72 versus
1.32  3.08, P  0.03), 44 (20.40  29.86 versus 5.00 
11.65, P  0.03), and 45 (32.32  45.52 versus 7.32 
16.54, P  0.04). Although there was no statistically
significant difference in the distribution of tumor types in
the genotypes, as compared by 2, null mice had a
smaller proportion of aggressive tumors than / mice
(Figure 5). Fifteen of the 25 tumors noted grossly (15 of
25, 60%) in Snai2-null mice were hyperplastic lesions or
benign papillomas, whereas hyperplastic lesions and
papillomas constituted 15 of 36 (42%) of the tumors in
/ mice. Twelve of 36 (33%) of the tumors in / mice
and 4 of 25 (16%) of the tumors in Snai2-null mice were
the more mesenchymal-appearing spindle cell or ana-
plastic tumors. None of the mice developed metastases.
Statistically significant differences between sexes within
genotypes in tumor number, size, or total area were not
observed. Overall, these findings suggest that the con-
version of benign papillomas to miSCCs and malignant
epithelial tumors to spindle cell and anaplastic tumors
was slower in Snai2-null mice than in / mice.
Expression of Snai1 and Snai2
Given the small number of epithelial tumors available for
RNA analysis, relative expression values from all epithe-
lial tumors (papillomas, miSCCs, and SCCs) were pooled
and compared with the pooled values from spindle cell
and anaplastic tumors. Hyperplastic lesions were not
included. These analyses included 10 / spindle cell
and anaplastic tumors, four null spindle cell tumors, six
/ epithelial tumors, and five null epithelial tumors.
Snail1 and Snai2 expression levels in normal skin were
provided by analysis of RNA samples from two / mice
and two null control mice.
Quantitative RT-PCR for Snai2 expression was per-
formed only on RNA from / tumors. There was signif-
icantly higher expression of Snai2 in both epithelial tu-
mors (P  0.02) and spindle cell tumors (P  0.04) than
in normal skin (Figure 6). The difference between Snai2
expression in the epithelial tumors versus the spindle
tumors was also significant (P  0.05), with higher ex-
pression in epithelial than in spindle cell tumors. In con-
trast to Snai2 expression, Snai1 expression in/ tumors
was higher in spindle cell tumors than in epithelial tumors
(Figure 6). There was significantly increased Snail ex-
pression in both the / (P  0.009) and null (P  0.03)
spindle cell tumors compared with epithelial tumors in the
same genotype. There was also significantly higher Snai1
expression in null epithelial tumors than in / epithelial
tumors (P  0.031), and there was significantly higher
Snai1 expression in the null spindle cell tumors than in
normal skin from the null mice (P  0.05). There was no
significant difference in Snai1 expression between nor-
mal / skin and either the epithelial or the spindle cell
tumors from / mice.
Expression of Snai2 and Snail Target Genes
Snai2 expression has been reported to repress Krt8 expres-
sion in a mammary epithelial cell line23 and Krt8 is aber-
rantly expressed in the epidermis of Snai2-null mice (manu-
script in submission). In keeping with these reports, Krt8
mRNA expression was minimal in the normal skin of control
/ mice and significantly higher (P  0.05) in the normal
skin of control null mice (Figure 7A). Krt8 expression was
Figure 5. As shown in this graph of the proportion of tumor types for each
genotype, Snai2-null mice developed fewer aggressive spindle cell and
anaplastic tumors than / mice. The two genotypes developed similar
proportions of miSCCs and SCCs. Differences in lesion distribution between
the two genotypes were not significant when compared by 2 analysis.
Table 1. Tumor Summary
Genotype Mice with tumors* (%) Onset of first tumor† (week) Tumors per mouse‡ Tumor area (mm2)
/ 80.0 42.4  3.8 1.9  1.5 66.9  212.6
/ 72.2 43.5  5.6 1.4  1.5 32.7  64.0
Data are given as mean  SD.
*Reflects percentage of mice remaining on the study past 35 weeks of exposure that developed skin tumors.
†Does not include mice that did not develop tumors.
‡Includes mice that did not develop tumors.
Figure 4. Calculation of tumor burden (total tumor area per mouse) for each
genotype revealed significant differences between the genotypes at most
time points between 39 and 45 weeks of exposure. *P  0.04.
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also significantly higher in null epithelial tumors (P 0.001)
and spindle cell tumors (P 0.02) compared with the same
tumor types from the / mice. There was no significant
difference in Krt8 expression among normal skin, epithelial
tumors, and spindle cell tumors of null mice. Although Krt8
expression has been reported to be a marker of skin tumor
progression in UVR-induced mouse skin tumors,24 we ob-
served that Krt8 expression levels in the / epithelial
tumors and the spindle tumors were significantly lower (P
0.009 and 0.0002, respectively) than expression in normal
skin. In addition, there was significantly less Krt8 expression
in the / spindle cell tumors than in the / epithelial
tumors (P  0.02).
The CDH1 gene has been reported to be a target of
transcriptional repression by both Snai1 and Snai2.8,25
As expected in tumors expressing high levels of Snai1,
there was significantly lower Cdh1 expression in the spin-
dle cell tumors from the / mice as compared with
normal control skin (P  0.006) or epithelial tumors (P 
0.0003). However, the same difference was not seen in
spindle cell tumors from null mice. Cdh1 expression did not
change significantly from control skin in either the epithelial
or spindle cell null tumors. Moreover, there was significantly
higher Cdh1 expression in spindle cell tumors from the null
mice as compared with those from / mice (P  0.03)
(Figure 7B). Thus, in the absence of Snai2 expression, even
elevated levels of Snai1 were unable to lead to significantly
suppressed Cdh1 expression in spindle cell tumors. These
findings suggest that spindle cell tumors in/mice had a
moremesenchymal phenotype thanmorphologically similar
tumors in Snai2-null mice.
In both the Snai2-null mice and / mice, there was
significantly lower Vim expression in epithelial tumors
compared with normal control skin (P  0.007 and P 
0.03, respectively) (Figure 7C). In addition, in the null
mice there was significantly less Vim expression in the
spindle tumors as compared with the normal skin (P 
0.0298). In both the / and null mice, spindle cell
tumors expressed significantly more Vim than did the
epithelial tumors in the same genotype (P  8  105
and P  0.04, respectively), as expected if these spindle
cell tumors have a more mesenchymal phenotype. How-
ever, Vim expression did not differ significantly between
the two genotypes in normal skin, epithelial tumors, or
spindle cell tumors. Thus, levels of Vim expression did not
reflect a difference between/ and Snai2-null tumors in
the mesenchymal character of the spindle cell tumors.
Mmp2 has been shown to be induced by Snai1 expres-
sion,26,27 as corroborated by this study (Figure 7D). In
both the / and null tumors, there was higher Mmp2
expression in the spindle cell tumors expressing in-
creased levels of Snai1 than in the epithelial tumors (P 
0.02 and P  0.05, respectively). In addition, both epi-
thelial and spindle cell tumors from / mice had higher
Mmp2 expression than those from null mice; for epithelial
tumors, this difference was significant (P  0.02). These
findings suggest that Snai2 also contributed to Mmp2
expression in / tumors.
Immunohistochemical Characterization of
Spindle Cell Tumors
Spindle cell tumors arising in Snai2-null mice demon-
strated somewhat stronger immunoreactivity for the epi-
thelial markers Krt8, Krt14, and Cdh1 than / spindle
cell tumors (Figure 8). In normal skin, Cdh1 immunore-
activity was localized to the cell membrane; however, in
Figure 6. Quantitative RT-PCR analysis of normal skin (basal), epithelial
tumors, and spindle cell tumors from / and Snai2-null mice revealed
differing patterns of expression for Snai1 and Snai2 in epithelial and spindle
cell tumors of / and Snai2-null mice. A: Snai2 expression was signifi-
cantly higher in epithelial and spindle cell tumors than in normal skin of/
mice. *P  0.04. Snai2 expression was also significantly higher in epithelial
than in spindle cell tumors of these mice. #P 0.05. Expression of Snai2 was
not evaluated in Snai2-null mice. B: Snai1 expression was significantly
higher in Snai2-null spindle cell tumors than in normal skin from Snai2-null
mice. *P  0.05. Snai1 expression was significantly higher in epithelial
tumors of Snai2-null mice than in epithelial tumors of / mice. *P  0.03.
In addition, there was significantly increased expression of Snai1 in spindle
cell tumors of both / and Snai2-null mice compared with epithelial
tumors in the same genotype. #P  0.03.
Figure 7. Quantitative RT-PCR analysis of normal skin (basal), epithelial
tumors, and spindle cell tumors from / and Snai2-null mice showed
altered expression of some Snail family target genes. A: Krt8 expression was
significantly elevated in skin, epithelial tumors, and spindle cell tumors of
Snai2-null mice compared with similar samples from / mice. *P  0.05.
B: Cdh1 expression was significantly higher in the spindle cell tumors of
Snai2-null mice compared with the same tumor type from / mice. *P 
0.05. C: Significant differences between / and Snai2-null mice for Vim
expression were not seen in normal skin, epithelial tumors, or spindle cell
tumors. However, for both genotypes, both normal skin and spindle cell
tumors expressed significantly more Vim than epithelial tumors. D: Mmp2
expression was significantly higher in the spindle cell tumors of / com-
pared with Snai2-null mice. *P  0.05.
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all of the spindle cell tumors, Cdh1 immunoreactivity was
cytoplasmic, indicating a redistribution of Cdh1 in these
neoplastic cells. Despite the marked difference in Krt8
mRNA levels between / and Snai2-null spindle cell
tumors, expression of Krt8 protein, as revealed by immuno-
histochemistry, was only modestly elevated in Snai2-null
spindle cell tumors compared with / tumors (Figure 9).
As illustrated in Figure 9, however, genotype-related differ-
ences in Krt8 expression were clearly visible both in unex-
posed skin and in SCCs. Detection of the proliferation
marker Mki67 demonstrated slightly fewer proliferating cells
in the Snai2-null spindle cell tumors than in the/ tumors.
Discussion
Snai2 and Epidermal Proliferation
Very early increases in skin thickness are indicators of
UVR-induced dermal edema and inflammation, whereas
later changes reflect epidermal and dermal changes, as
well as altered hair growth patterns. Other studies in our
laboratory have shown that the initial cutaneous inflam-
matory response to UVR is suppressed in Snai2-null mice
compared with / mice. As expected, initial depilation
followed by UVR exposure stimulated synchronized hair
growth in all mice. The initial hair growth cycle was some-
what prolonged in the Snai2-null mice; however, by 3
months of UVR exposure, hair cycles in all mice were
essentially asynchronous and did not differ between the
genotypes. Our findings of decreased skin and, in par-
ticular, epidermal thickness late in the study suggest a
decreased proliferative response of Snai2-null epidermis
to chronic UVR exposure compared with / epidermis.
This decrease was somewhat unexpected because
Snai1 has been shown to block cell-cycle progression by
repressing cyclin D transcription and overexpression of
SNAI2 in keratinocytes in vitro results in decreased pro-
liferation without changes in cyclin D expression.16 Our
recent work, however, demonstrated decreased expres-
sion of cyclin D2, cyclin G2, and epithelial mitogen in
untreated Snai2-null epidermis, as compared with un-
treated/ epidermis (manuscript in submission). More-
over, UVR induction of keratin 6 (Krt6), a marker of pro-
liferation, is delayed in Snai2-null compared with /
mice, suggesting an impaired proliferative response.22
Taken together, our findings from this study and previous
studies, suggest that Snai2 expression is required for a
robust proliferative epidermal response to UVR. De-
creased UVR-induced epidermal proliferation in Snai2-
null skin may have contributed to the development of
fewer tumors, smaller tumors, and less aggressive tu-
mors in the null mice than in the / mice because
decreased epidermal proliferation would decrease the
potential to accumulate mutations contributing to tumor
progression. It is also possible that epidermal cell transit
time was decreased in Snai2-null mice, leading to in-
creased epidermal cell loss and reduced epidermal
thickness, even in the absence of altered proliferation.
This possibility remains to be investigated.
Snai2 and Cutaneous Inflammation
In humans, UVR-induced cutaneous inflammation has
been shown to drive the conversion of actinic keratosis to
SCC.28 Chronic UVR exposure causes constitutive induc-
tion of cyclooxygenase 2 (Ptgs2) in the skin, which results
in increases in prostaglandin E2 (PGE2), inflammation,
Figure 8. As shown in this figure, spindle cell tumors from Snai2-null mice
had decreased Mki67 staining compared with / spindle cell tumors and
had increased staining for Krt8, Krt14, and Cdh1.
Figure 9. Immunohistochemistry for Krt8 revealed widespread Krt8 expres-
sion in the unexposed skin of Snai2-null mice (A) compared with no
detectable Krt8 expression in the unexposed skin of / (B). There was
greater Krt8 immunoreactivity in the SCC of Snai2-null mice (C) compared
with SCC in / mice (D). On the other hand, there was much less
difference in the difference in Krt8 immunoreactivity of spindle cell tumors of
/ mice (E) versus Snai2-null mice (F). Original magnifications, 600.
1636 Newkirk et al
AJP November 2007, Vol. 171, No. 5
and reactive oxygen intermediates.29 PGE2 can act as a
tumor promoter by contributing to the uncontrolled pro-
liferation of damaged cells.29 High levels of Ptgs2 ex-
pression have been associated with more aggressive
tumors, and oral or topical Ptgs2 inhibitors protect
against skin tumor development in UVR-exposed mice.29
The cancer preventive effect of Ptgs2 inhibition may be
attributable to decreased UVR-induced inflammation or
to enhanced apoptosis of UVR-damaged keratinocytes
because PGE2 is required for the growth of skin tumor
cells.28
The present studies demonstrated significantly fewer
Cde3-positive cells in the dermis of null mice chronically
exposed to UVR, in comparison with similarly treated/
mice. At the same time, the numbers of mast cells in the
dermis of both unexposed and chronically UVR-exposed
Snai2-null epidermis were significantly higher than the
numbers in / skin. Numbers of neutrophils did not
differ between / and Snai2-null skin either before or
after chronic UVR exposure. Thus, although Snai2 ex-
pression clearly had an impact on the inflammatory re-
sponse of the skin to UVR, the implications of this altered
response for skin carcinogenesis are not immediately
apparent.
The finding of increased dermal mast cells after
chronic UVR exposure has been previously reported in
mice.22 The functional significance of increased mast
cells after chronic UVR-exposure is still unclear. Hart and
colleagues30 showed a direct correlation between the
number of dermal mast cells and the degree of UVR-
associated immunosuppression. It is hypothesized that
these increased numbers of mast cells and subsequent
immunosuppression would allow the development of skin
tumors; however, no relationship has been identified be-
tween the number of mast cells and the incidence of skin
tumors.31
Snai2 and Skin Carcinogenesis
The expression of detectable levels of various keratins
and Cdh1 in the spindle cell tumors in this study sug-
gested that they were of epithelial origin, as proposed by
other investigators.17 The occurrence of a similar variety
of tumor types in both Snai2-null and / mice indicated
that Snai2 was not required for tumor development or
progression. However, Snai2-null mice had a consistently
lower tumor burden than / mice and the null mice
developed a higher proportion of benign tumors. Spindle
cell tumors in / mice had a more mesenchymal phe-
notype than spindle cell tumors in Snai2-null mice. This
suggested that Snai2 expression in / tumors en-
hanced tumor progression and EMT in response to
chronic UVR exposure.
In / mice, Snai2 expression was higher in epithelial
tumors than in spindle cell tumors, whereas Snai1 expres-
sion was higher in the more aggressive spindle tumors.
This finding supports the findings of Kurrey and col-
leagues32 who reported that Snai2 expression was effec-
tive in triggering EMT but that maintenance of EMT re-
quired continuous Snai1 expression. In the epithelial
ovarian cancer cell line, SKOV3, Snai2 suppressed ex-
pression of adherens junction (Cdh1 and -catenin), tight
junction (occludin and ZO-1), and desmosome (desmo-
glein 2) components, whereas Snai1 only suppressed
expression of adherens and tight junction components.
Furthermore, Snai2 expression preceded Snai1 expres-
sion in response to hypoxic conditions.32 Savagner and
colleagues14 found that Snai2 expression induced the
first phase of growth factor-induced EMT, including des-
mosome dissociation, cell spreading, and initiation of cell
separation in a rat bladder carcinoma cell line (NBT-II).
However, Snai2 expression alone was not able to induce
the second phase of EMT, which included enhanced cell
motility, repression of cytokeratin expression, and activa-
tion of vimentin expression. In the present study, signifi-
cantly increased Snai1 expression in the epithelial tumors
of Snai2-null mice compared with / mice suggested
that Snai1 expression might have substituted for en-
hanced Snai2 expression in driving evolution of epithelial
tumors to a more aggressive phenotype.
The importance of Snai1 expression in epithelial tumor
progression has previously been demonstrated. In a
study comparing the expression of Snai1 and Snai2 in
invasive and noninvasive mouse epidermal keratinocyte
cell lines, it was shown that invasive cell lines expressed
Snai1, whereas both types of cell line expressed Snai2.8
Furthermore, canine kidney epithelial cells (MDCK cells)
overexpressing Snai1 or Snai2 demonstrated different
morphologies when transplanted into BALB/C nude
(Foxn1nu) mice. Snai1-expressing cells formed undiffer-
entiated spindle cell tumors with no evidence of epithelial
differentiation, whereas Snai2-expressing cells formed
carcinosarcomas characterized by areas of glandular
differentiation surrounded by proliferating undifferenti-
ated malignant spindle cells.33 Similarly, Snai1-trans-
fected MDCK cells with decreased Cdh1 expression
demonstrated increased motility and invasion in in vitro
assays and increased tumor growth in an athymic nu/nu
xenograft model.8 The increased invasiveness of these
cells suggests that ectopic expression of SNAI1 also
affects other genes involved in motility and migration, in
addition to genes regulating cell adhesion,8 In addition,
SNAI1 expression has been shown to correlate inversely
with the grade of differentiation of human breast carcino-
mas.34 In infiltrating ductal carcinomas, SNAI1 expres-
sion was associated with the presence of lymph node
metastases, whereas all SNAI1-negative infiltrative ductal
carcinomas lacked lymph node metastases.34 These
data further demonstrate a role for SNAI1 in inducing an
invasive and migratory phenotype in epithelial cells and
identify SNAI1 expression as a marker of metastatic
potential.34
Snai2 Targets during EMT in Skin Tumors
Cdh1 is a cell-cell adhesion molecule that complexes
with the actin cytoskeleton via cytoplasmic catenins to
form and maintain intercellular junctions and polarization
of epithelial cells.35,36 Disruption of Cdh1-mediated cell
adhesion commonly occurs during the transition from
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noninvasive tumors to invasive malignant carcino-
mas.37,38 Decreased CDH1 expression is a hallmark of
EMT.39 Both SNAI1 and SNAI2 have been shown to re-
press CDH1 expression and induce EMT.8,14,25 In the
present studies, Cdh1 expression at both the RNA and
protein levels was lower in the spindle cell tumors than in
the epithelial tumors from / mice, but not in tumors
from the Snai2-null mice. The finding of persistent Cdh1
expression in spindle cell tumors from the Snai2-null mice
is consistent with the role of SNAI2 in repressing CDH1
expression and fostering EMT. This finding suggests that
although the spindle cell tumors in the two genotypes
were morphologically similar, spindle cell tumors in the
Snai2-null mice maintained a more epithelial gene ex-
pression profile than those in / mice. Thus EMT was
impaired in UVR-induced skin tumors in Snai2-null mice.
Matrix metalloprotease expression has also been
strongly linked with EMT and carcinoma progression
driven by Snail family transcription factors. Transfection
of human hepatocellular carcinoma cell lines with Snai1
increased expression of MMP1, MMP2, MMP7, and
MMP14; decreased CDH1 expression; and enhanced
tumor invasive activity.27 In another study, human oral
SCC cells transfected with Snai1 developed a mesenchy-
mal phenotype, increased invasive behavior, de novo
expression of VIM, and high levels of Mmp2 activity.26
Moreover, overexpression of MMP2 has been demon-
strated in stromal and neoplastic cells near the invasive
front of a neoplasm, a site of EMT.40,41 Our study found
that Mmp2 expression was greatest in the spindle cell
tumors of both / and Snai2-null mice; however, Mmp2
expression was significantly higher in / spindle cell
tumors than in Snai2-null tumors. This finding was con-
sistent with impaired EMT in Snai2-null mice as sug-
gested by Cdh1 findings.
Loss of keratin expression accompanied by de novo
expression of Vim is a further characteristic of EMT in
carcinomas. In the present studies, Vim expression was
higher in both the / and null spindle cell tumors than
in the epithelial tumors. In the absence of Snai2, there was
decreased Vim and significantly increased Cdh1 expres-
sion in the spindle cell tumors, supporting the conclusion
that EMT was impaired in Snai2-null tumors. We saw mark-
edly elevated Krt8 transcription in the skin and skin tumors
of Snai2-null mice compared with / mice. We observed
enhanced expression of Krt8 in both unexposed epidermis
and SCC of Snai2-null mice, a finding in keeping with levels
of mRNA expression. However, the difference in mRNA
expression in spindle cell tumors was not reflected in
markedly altered immunohistochemical reactivity for Krt8.
In general, Krt8 expression is regarded as a marker of
skin tumor progression, because the KRT8 gene is not
normally expressed in the adult epidermis, but is often
aberrantly expressed in SCCs.24,42,43 Moreover, expres-
sion of exogenous KRT8 in a variety of cell lines results in
anchorage-independent growth, shortened doubling
times, increased invasive and migratory capabilities, and
apoptosis resistance in vitro as well as enhanced metas-
tasis in vivo.44–46 After treatment with a promoter, trans-
genic mice that express human Krt8 and Hras in the skin
develop more aggressive undifferentiated SCC than mice
expressing Hras only.47 However, an effect of Krt8 ex-
pression on spindle cell conversion has not been re-
ported. Nor has the expression of Krt8 in spindle cell
tumors been investigated. To date, all reports of keratin
immunoreactivity in spindle cell tumors of mouse skin
have used either pan-cytokeratin antibodies or antibod-
ies against Krt14 alone.48–51 Thus, although Krt8 expres-
sion in mouse skin is believed to be modulated at the
transcriptional level,24 our results suggest that Krt8 lev-
els, at least in spindle cell tumors, may be regulated by
mechanisms other than transcriptional control.
In summary, our studies show that Snai2 expression is
not required for the development of UVR-induced SCC or
their progression to more mesenchymal tumor types.
However, tumor growth and progression were slower in
Snai2-null than in / mice and spindle cells tumors in
Snai2-null mice maintained a more epithelial phenotype
than tumors of similar appearance in / mice. Our
studies support the conclusions of other investigators
regarding the relative roles of SNAI1 and SNAI2 in tumor
progression. It seems that increased SNAI2 expression
precedes increased SNAI1 expression during tumor de-
velopment and that enhanced SNAI1 expression is re-
quired for complete EMT to occur. Moreover, our studies
support a role for both SNAI1 and SNAI2 in modulating
expression of the CDH1 and MMP2 genes during tumor
evolution. Our studies also suggest additional roles for
SNAI2 in UVR-induced epidermal proliferation and cuta-
neous inflammation.
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